Agilent Technologies has introduced a suite of electronics and software products designed for use with existing nuclear MR spectroscopy systems.
A new magnetic resonance spectroscopy (MRS) technique may offer a method to detect and track a protein associated with a genetic mutation in brain tumor cancer cells. The method could inform diagnosis of glioma and provide prognostic information, according to a study published online Jan. 26 in Nature Medicine.
Roberto R. Gil, PhD, and Rongchao Jin, PhD, of Carnegie Mellon University of Pittsburgh have used nuclear MR to analyze the structure of infinitesimal gold nanoparticles, which could advance the development and use of the tiny particles in drug development.
The final diagnostic form the evolving hybrid PET/MR tree will take is uncertain, but it has already begun to blossom. Thus, the low-hanging clinical fruit has lured a number of medical centers to early adoption. Experts weigh in on the potential that PET/MR may hold for various neurologic, oncologic and cardiovascular conditions.
Agilent Technologies and the University of Technology, Sydney in Australia have established a joint nuclear MR research facility.
Near-infrared spectroscopy provides rapid, automated detection of extensive lipid-core plaques that are associated with a high risk of periprocedural MI, presumably due to embolization of plaque contents during coronary intervention, according to a substudy of the COLOR registry, published in the October issue of Circulation: Cardiovascular Interventions.
Researchers from the University of California, Davis have modified iPhones and transformed them into devices able to provide near medical-quality images and used them to perform detailed microscopy and spectroscopy. The team will present their findings at the Optical Society’s Annual Meeting, Frontiers in Optics 2011, in San Jose, Calif., Oct. 16-20.
Measuring bone marrow cellularity is typically done using a biopsy of the iliac crest, but a recent study published in the Journal of Nuclear Medicine indicates that MRI images may also adequately, and noninvasively, measure in vivo bone marrow cellularity.
|
|
|
|
RSS 
